Klee George G
Department of Laboratory Medicine and Pathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Clin Chem Lab Med. 2004;42(7):752-7. doi: 10.1515/CCLM.2004.127.
Reference intervals for healthy subjects and diseased populations are important benchmarks for the clinical interpretation of laboratory test values. It is important that the testing conditions used to collect the reference data be closely matched with the testing conditions used for patient data. Interlaboratory differences and intralaboratory changes, especially changes in analytic set-points, can markedly affect the clinical interpretation of tests. If laboratory testing methods could be harmonized, laboratories could potentially share reference data to make these data more reliable. This chapter illustrates the use of reference intervals for healthy subjects and reference data from diseased populations for medical decisions. One example illustrates the effects of age differences on test result interpretation. Other examples illustrate use of thyroid-stimulating hormone (TSH) and combinations of TSH with free thyroxine measurements for diagnosing thyroid diseases. Both univariate and multivariate reference intervals are discussed. Model systems for using disease prevalence and cost utility functions are provided to illustrate optimization of medical decisions.
健康受试者和患病人群的参考区间是实验室检测值临床解读的重要基准。用于收集参考数据的检测条件与用于患者数据的检测条件紧密匹配非常重要。实验室间差异和实验室内变化,尤其是分析设定点的变化,会显著影响检测的临床解读。如果实验室检测方法能够统一,各实验室就有可能共享参考数据,使这些数据更可靠。本章阐述了健康受试者参考区间和患病人群参考数据在医疗决策中的应用。一个例子说明了年龄差异对检测结果解读的影响。其他例子说明了促甲状腺激素(TSH)以及TSH与游离甲状腺素测量值组合在诊断甲状腺疾病中的应用。同时讨论了单变量和多变量参考区间。提供了使用疾病患病率和成本效用函数的模型系统,以说明医疗决策的优化。